Barriers and Facilitators to Conducting Oncology Clinical Trials in the UAE.

ABSTRACT: Cancer research and clinical trials are essential to improve cancer patients' outcomes and advance the oncology field. The United Arab Emirates (UAE) has been lagging in cancer research with many barriers, including healthcare, institutional, regulatory, patient and community, the global oncology community, and the pharmaceutical industry. In this report, we try to address these challenges from our perspective. Making clinical trials accessible for cancer patients in the UAE requires a collaborative approach from all stakeholders and serious consideration for the greater cause to improve the patient's outcome and contribute to the advancement of the cancer field worldwide. There has been significant support from the UAE government and the regulators in the UAE to facilitate and encourage r

SUBMITTER: Al-Shamsi HO 

PROVIDER: S-EPMC9680222 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature